Benlysta Alternatives Compared
| Benlysta (belimumab) | Saphnelo (anifrolumab) | Hydroxychloroquine |
|
|---|
| Benlysta (belimumab) | Saphnelo (anifrolumab) | Hydroxychloroquine |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Benlysta is an injectable non-steroid prescription medicine used with other medicines to treat systemic lupus erythematosus (SLE) and active lupus nephritis (lupus-related kidney inflammation) in... View more |
Prescription only
Prescribed for Lupus. Saphnelo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Rheumatoid Arthritis, Lupus, Lichen Planopilaris, Lyme Disease - Arthritis, Dermatomyositis, Malaria, Malaria Prevention, Sjogren's Syndrome, Undifferentiated Connective Tissue... View more |
Related suggestions |
|||||||||||||||||||||||
| More about Benlysta (belimumab) | More about Saphnelo (anifrolumab) | More about Hydroxychloroquine | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Benlysta has an average rating of 7.8 out of 10 from a total of 65 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 9% reported a negative effect. |
Saphnelo has an average rating of 7.9 out of 10 from a total of 11 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 9% reported a negative effect. |
Hydroxychloroquine has an average rating of 6.4 out of 10 from a total of 356 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Benlysta side effects |
View all Saphnelo side effects |
View all Hydroxychloroquine side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
N/A |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Benlysta prices |
View all Saphnelo prices |
View all Hydroxychloroquine prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
N/A |
Plaquenil, Sovuna | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
465.6 hours |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 250 drugs are known to interact with Benlysta:
|
A total of 234 drugs are known to interact with Saphnelo:
|
A total of 592 drugs are known to interact with Hydroxychloroquine:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
March 09, 2011 |
July 30, 2021 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Lupkynis
Lupkynis is used to treat active lupus nephritis in adults with SLE. Lupkynis for lupus is a ...
Saphnelo
Saphnelo is used for moderate to severe SLE (lupus) for adults who are also receiving other lupus ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Afinitor Disperz
Afinitor Disperz is used for subependymal giant cell astrocytoma, tuberous sclerosis complex
Arava
Arava (leflunomide) is used to treat the symptoms of rheumatoid arthritis and help reduce joint ...
Arzerra
Arzerra is used to treat chronic lymphocytic leukemia (CLL), usually in combination with other ...
Aubagio
Aubagio (teriflunomide) is used to reduce flare-ups in people with relapsing multiple sclerosis ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.